+検索条件
-Structure paper
タイトル | Structural basis of negative regulation of CRISPR-Cas7-11 by TPR-CHAT. |
---|---|
ジャーナル・号・ページ | Signal Transduct Target Ther, Vol. 9, Issue 1, Page 111, Year 2024 |
掲載日 | 2024年5月13日 |
著者 | Tian Hong / Qinghua Luo / Haiyun Ma / Xin Wang / Xinqiong Li / Chongrong Shen / Jie Pang / Yan Wang / Yuejia Chen / Changbin Zhang / Zhaoming Su / Haohao Dong / Xiaodi Tang / |
PubMed 要旨 | CRISPR‒Cas7-11 is a Type III-E CRISPR-associated nuclease that functions as a potent RNA editing tool. Tetratrico-peptide repeat fused with Cas/HEF1-associated signal transducer (TPR-CHAT) acts as ...CRISPR‒Cas7-11 is a Type III-E CRISPR-associated nuclease that functions as a potent RNA editing tool. Tetratrico-peptide repeat fused with Cas/HEF1-associated signal transducer (TPR-CHAT) acts as a regulatory protein that interacts with CRISPR RNA (crRNA)-bound Cas7-11 to form a CRISPR-guided caspase complex (Craspase). However, the precise modulation of Cas7-11's nuclease activity by TPR-CHAT to enhance its utility requires further study. Here, we report cryo-electron microscopy (cryo-EM) structures of Desulfonema ishimotonii (Di) Cas7-11-crRNA, complexed with or without the full length or the N-terminus of TPR-CHAT. These structures unveil the molecular features of the Craspase complex. Structural analysis, combined with in vitro nuclease assay and electrophoretic mobility shift assay, reveals that DiTPR-CHAT negatively regulates the activity of DiCas7-11 by preventing target RNA from binding through the N-terminal 65 amino acids of DiTPR-CHAT (DiTPR-CHAT). Our work demonstrates that DiTPR-CHAT can function as a small unit of DiCas7-11 regulator, potentially enabling safe applications to prevent overcutting and off-target effects of the CRISPR‒Cas7-11 system. |
リンク | Signal Transduct Target Ther / PubMed:38735995 / PubMed Central |
手法 | EM (単粒子) |
解像度 | 2.86 - 3.53 Å |
構造データ | EMDB-37640, PDB-8wm4: EMDB-37649, PDB-8wmc: EMDB-37653, PDB-8wmi: EMDB-37655, PDB-8wml: |
化合物 | ChemComp-ZN: |
由来 |
|
キーワード | IMMUNE SYSTEM / CRISPR-Cas / Gene editing / TPR-CHAT / Cas7-11 |